REDWOOD CITY, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...

Following completion of the ongoing Phase 2a proof-of-pharmacology study with BMB-101, Bright Minds plans to select and ...

A gene on the X chromosome revs up inflammation in the female brain, which may explain why rates of multiple sclerosis are ...

This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...

A 15-year-old girl with a rare chromosome disorder received a complete room renovation Friday that her family says will ...

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Dasatinib Tablets in strengths ...

When Skye Scott took her son to a paediatrician, she never imagined he would be diagnosed with the life-changing Duchenne ...

The international research team, which included CSIR-Centre for Cellular and Molecular Biology (CCMB), discovered that ...

India’s political landscape is witness to an innovative private-public partnership model. The upgrades are rapid and arrive ...

His decoding of the blueprint for life with Francis H.C. Crick made him one of the most important scientists of the 20th ...